Insurance Australia Group Ltd Reports Slight fall in the profit for FY 18

Insurance Australia Group

Slight fall in the profit for FY 18: Insurance Australia Group Ltd.’s (ASX: IAG) stock fell 5.8% on August 15, 2018 after the company for FY 18 reported 0.6% fall in the net profit after tax to $929m. During 2018, Like-for-like Gross Written Premium grew over 4% and the group posted underlying margin of 14.1%. There is strong performance from Australia Consumer, modest improvement from Australia Business and continued performance from New Zealand during 2018.

[optin-monster-shortcode id=”wxhmli4jjedneglg1trq”]

The company has reported margin of 18.3% for 2018, which is slightly higher than guidance due to favourable perils outcome and higher than expected reserve releases. Moreover, in 2018, IAG has agreed sale of operations in Thailand, Indonesia and Vietnam and therefore FY19 net profit is expected to be more than $200m. The company has increased the full year dividend by 3% to 34 cents, fully franked. Additionally, for FY 19, Reported insurance margin is expected to be in the range of 16.0-18.0% and GWP growth to be between 2-4%. Therefore, IAG stock has fallen 0.72% in three months as on August 14, 2018 and is trading at a P/E of 18.84x.

IAg report

FY 18 Financial Performance (Source: Company Reports)

Dividend Stocks To Buy

The Income available from dividends remains attractive for many investors.

We take a look at the best yields on the market and assess what they say about a company’s prospect.

One Thing is certain, though, Australia interest rates are still low, making income difficult to come by and keeping the focus for many investors on high yielding stocks. Kalkine’s team of analysts bought you handpicked report for “Top 25 Dividend Stocks For 2018.”

ASX-relevant Special Reports are published year-round to provide a detailed analysis into an investing opportunity or a potential risk to your portfolio.

Click here to get your free report.


Disclaimer

The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. Kalkinemedia.com and associated websites are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). website), employees and/or associates of Kalkine Pty Ltd do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.

Checkout our Free Dividend Stocks Report

Specially made for income-hungry investors, Invest in growing Franked Dividends an opportunity that should not be missed.


6 Cannabis Stocks under Investor’s Limelight…

Cannabis companies that sell both medicinal weed and recreational pot. Marijuana stocks to look at. Marijuana mergers and acquisitions. Dispensary data analytics. Upcoming marijuana IPO’s Those phrases have become increasingly common as marijuana legalization spreads.

Global spending on legal cannabis is expected to grow 230% to $32 billion in 2020 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. As of June 29, 2018 the United States Marijuana Index, despite a lot of uncertainty around regulations, has over the past 1 year gained 71.49%, as compared to about 12% gain seen by the S&P 500.

Click here for your FREE Report